This programme is a comprehensive guide and matching service for non-dilutive startup funding (grants, tax credits, innovation awards) in 2026, not a single grant itself. It exists to help founders identify and apply to the right government and institutional grants (e.g., Innovate UK, SBIR/STTR, EIC) as a first layer of capital, avoiding equity dilution for R&D-heavy, pre-revenue, IP-driven ventures.

Since this is a guide/service rather than a grant programme, the 'selection criteria' are the eligibility filters and scoring rubrics of the underlying grants it matches to. Based on the page content, the key criteria for the matched grants are: 1) Technology Readiness Level (TRL) alignment with the specific programme (e.g., TRL 2 for early research vs. TRL 5-8 for commercialisation); 2) Clear, specific commercialisation narrative with named target customers, LOIs, pilots, or pre-orders (not generic market size); 3) Detailed, justified budget with named personnel, day rates, and links to deliverables (no lump sums); 4) Eligibility: geography (UK, US, EU incorporation), company stage (pre-revenue vs. growth), and sector (deep-tech, biotech); 5) Strong R&D evidence and IP position (patents, publications).

The page does not list specific past winners. However, the archetype described is a UK, US, or EU-based deep-tech startup founder who has successfully used non-dilutive grants as a 'first layer' of funding. Typical winners are R&D-heavy, pre-revenue companies with strong IP, often in biotech, engineering, or advanced computing, who have secured Innovate UK, SBIR/STTR, or EIC Pathfinder awards.

The platonic ideal applicant is a UK-incorporated, R&D-intensive deep-tech startup at TRL 3-5 with a provisional patent, strong academic endorsements, and a clear commercialisation path to named customers. They have a detailed, justified budget and a compelling narrative that the grant will de-risk the technology to the point where they can raise equity from a position of strength.